glucuronomannan

from Auricularia auricala; structure in first source

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Parkinsonian Disorders (Parkinsonism) 01/25/2021 - "In our previous study, we hydrolyzed the fucoidan from Saccharina japonica, obtaining three glucuronomannan oligosaccharides (GMn; GM1, GM2, and GM3) and found that GMn ameliorated behavioral deficits in Parkinsonism mice and downregulated the apoptotic signaling pathway, especially with GM2 showing a more effective role in neuroprotection. "
2.	Neoplasms (Cancer) 01/01/2023 - "In this paper, the anti-tumor effects of glucuronomannan oligosaccharides (Gx) and its sulfated derivatives (GxSy) on hepatocarcinoma Huh7.5 cells were investigated. " 01/01/2023 - "Glucuronomannan polysaccharide (Gx) is a subtype of fucoidans that possesses many bioactivities, but its anti-tumor activities in HCC have not been reported. " 01/01/2023 - "Comparison of anti-tumor activities and underlying mechanisms of glucuronomannan oligosaccharides and its sulfated derivatives on the hepatocarcinoma Huh7.5 cells."
3.	Lung Neoplasms (Lung Cancer) 11/15/2020 - "This suggests that glucuronomannan hexamer inhibits the proliferation of lung cancer through its binding to immunoglobulin." 11/15/2020 - "The anti-lung cancer activity of oligosaccharides derived from glucuronomannan was investigated. " 11/15/2020 - "Inhibition of glucuronomannan hexamer on the proliferation of lung cancer through binding with immunoglobulin G."

1.	Oligosaccharides
2.	fucoidan
3.	Polysaccharides (Glycans)
4.	Immunoglobulins (Immunoglobulin)
5.	Immunoglobulin G (IgG)